Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage

Journal of Neurochemistry

Volumn 117, Issue 6, 2011, Pages 1033-1046

  Pietrzak, MacIej ^a   Smith, Scott C ^a   Geralds, Justin T ^a   Hagg, Theo ^a   Gomes, Cynthia ^a   Hetman, Michal ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

apoptosis; DNA damage; neurodegeneration; nucleolus; ribosomal biogenesis; transcription

Indexed keywords

ATM PROTEIN; DNA; DNA DIRECTED RNA POLYMERASE; ENDONUCLEASE; ENDONUCLEASE I PPO1; ETOPOSIDE; PROTEIN P53; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOGENESIS; BRAIN NERVE CELL; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENETIC TRANSCRIPTION; MALE; NEOCORTEX; NERVE INJURY; NEUROTOXICITY; NEWBORN; NONHUMAN; NUCLEOLAR STRESS; PRIORITY JOURNAL; RAT; RIBOSOME; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK;

ATAXIA TELANGIECTASIA; RATTUS;

EID: 79958003442     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07279.x     Document Type: Article

References (51)

1. Berkovich E., Monnat R. J., Jr, and, Kastan M. B., (2007) Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat. Cell Biol. 9, 683-690. (Pubitemid 47214731)
2. Brasnjevic I., Hof P. R., Steinbusch H. W., and, Schmitz C., (2008) Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst) 7, 1087-1097.
3. Brooks P. J., (2008) The 8,5′-cyclopurine-2′- deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst) 7, 1168-1179.
4. Burger K., Muhl B., Harasim T., et al. (2010) Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J. Biol. Chem., 285, 12416-12425.
5. Caldecott K. W., (2008) Single-strand break repair and genetic disease. Nat. Rev. Genet. 9, 619-631.
6. Capranico G., Ferri F., Fogli M. V., Russo A., Lotito L., and, Baranello L., (2007) The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I. Biochimie 89, 482-489. (Pubitemid 46634701)
7. Covey J. M., Jaxel C., Kohn K. W., and, Pommier Y., (1989) Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res. 49, 5016-5022. (Pubitemid 19239335)
8. Ding Q., Markesbery W. R., Chen Q., Li F., and, Keller J. N., (2005) Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 25, 9171-9175. (Pubitemid 41500825)
9. Drygin D., Rice W. G., and, Grummt I., (2010) The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu. Rev. Pharmacol. Toxicol. 50, 131-156.
10. Enokido Y., Araki T., Tanaka K., Aizawa S., and, Hatanaka H., (1996) Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur. J. Neurosci. 8, 1812-1821. (Pubitemid 26302277)
11. Fortin D., McCormick C. I., Remsen L. G., Nixon R., and, Neuwelt E. A., (2000) Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model. Neurosurgery 47, 199-207. (Pubitemid 32047779)
12. Galburt E. A., Chadsey M. S., Jurica M. S., Chevalier B. S., Erho D., Tang W., Monnat R. J., Jr, and, Stoddard B. L., (2000) Conformational changes and cleavage by the homing endonuclease I-PpoI: a critical role for a leucine residue in the active site. J. Mol. Biol. 300, 877-887.
13. Garg L. C., DiAngelo S., and, Jacob S. T., (1987) Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Proc. Natl Acad. Sci. USA 84, 3185-3188. (Pubitemid 17085369)
14. Grummt I., (2003) Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev. 17, 1691-1702. (Pubitemid 36870332)
15. Habas A., Kharebava G., Szatmari E., and, Hetman M., (2006) NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3beta-induced apoptosis. J. Neurochem. 96, 335-348.
16. Han B. H., and, Holtzman D. M., (2000) BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci., 20, 5775-5781. (Pubitemid 30636906)
17. Herzog K. H., Chong M. J., Kapsetaki M., Morgan J. I., and, McKinnon P. J., (1998) Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science, 280, 1089-1091. (Pubitemid 28234952)
18. Hetman M., Kanning K., Smith-Cavanaugh J. E., and, Xia Z., (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular-signal-regulated kinase and phosphatidylinositol-3 kinase. J. Biol. Chem., 274, 22569-22580.
19. Honda K., Smith M. A., Zhu X., et al. (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J. Biol. Chem. 280, 20978-20986. (Pubitemid 40805655)
20. Isik S., Sano K., Tsutsui K., Seki M., Enomoto T., and, Saitoh H., (2003) The SUMO pathway is required for selective degradation of DNA topoisomerase IIβ induced by a catalytic inhibitor ICRF-193(1). FEBS Lett. 546, 374-378. (Pubitemid 36782442)
21. Kaasa S., Olsnes B. T., and, Mastekaasa A., (1988) Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy. Acta Oncol. 27, 241-246.
22. Kalita K., Kharebava G., Zheng J. J., and, Hetman M., (2006) Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity. J. Neurosci. 26, 10020-10032. (Pubitemid 44477163)
23. Kalita K., Makonchuk D., Gomes C., Zheng J. J., and, Hetman M., (2008) Inhibition of nucleolar transcription as a trigger for neuronal apoptosis. J. Neurochem. 105, 2286-2299. (Pubitemid 351782259)
24. Kathe S. D., Shen G. P., and, Wallace S. S., (2004) Single-stranded breaks in DNA but not oxidative DNA base damages block transcriptional elongation by RNA polymerase II in HeLa cell nuclear extracts. J. Biol. Chem. 279, 18511-18520. (Pubitemid 38623270)
25. Katyal S., and, McKinnon P. J., (2008) DNA strand breaks, neurodegeneration and aging in the brain. Mech. Ageing Dev. 129, 483-491.
26. Keramaris E., Hirao A., Slack R. S., Mak T. W., and, Park D. S., (2003) Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. J. Biol. Chem. 278, 37782-37789. (Pubitemid 37175305)
27. Kruhlak M., Crouch E. E., Orlov M., Montano C., Gorski S. A., Nussenzweig A., Misteli T., Phair R. D., and, Casellas R., (2007) The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature 447, 730-734. (Pubitemid 46889725)
28. Kruman I. I., Wersto R. P., Cardozo-Pelaez F., Smilenov L., Chan S. L., Chrest F. J., Emokpae R., Jr, Gorospe M., and, Mattson M. P., (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41, 549-561. (Pubitemid 38253067)
29. Maeda Y., Matsumoto K., Mizumatsu S., Tamiya T., Furuta T., and, Ohmoto T., (1999) Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model. Acta Med. Okayama 53, 5-11. (Pubitemid 129538456)
30. Markesbery W. R., and, Lovell M. A., (2006) DNA oxidation in Alzheimer's disease. Antioxid. Redox Signal. 8, 2039-2045. (Pubitemid 46489629)
31. Martin L. J., (2008) DNA damage and repair: relevance to mechanisms of neurodegeneration. J. Neuropathol. Exp. Neurol. 67, 377-387. (Pubitemid 351653537)
32. Martin L. J., Liu Z., Pipino J., Chestnut B., and, Landek M. A., (2008) Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex. Cereb. Cortex 26, 26.
33. Mok T. S., Lam K. C., Lee C., et al. (2005) Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Oncology 68, 485-492. (Pubitemid 41160981)
34. Monnat R. J., Jr, Hackmann A. F., and, Cantrell M. A., (1999) Generation of highly site-specific DNA double-strand breaks in human cells by the homing endonucleases I-PpoI and I-CreI. Biochem. Biophys. Res. Commun. 255, 88-93. (Pubitemid 29292069)
35. Morris E. J., and, Geller H. M., (1996) Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA Topo1: evidence for cell cycle-independent toxicity. J. Cell Biol. 134, 757-770. (Pubitemid 26269145)
36. Nitiss J. L., (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9, 338-350.
37. Olson M. O., (2004) Sensing cellular stress: another new function for the nucleolus? Sci. STKE 2004, pe10.
38. Parlato R., Kreiner G., Erdmann G., Rieker C., Stotz S., Savenkova E., Berger S., Grummt I., and, Schutz G., (2008) Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice. J. Neurosci. 28, 12759-12764.
39. Pozniak C. D., Radinovic S., Yang A., McKeon F., Kaplan D. R., and, Miller F. D., (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289, 304-306. (Pubitemid 30469909)
40. Riva D., Massimino M., Giorgi C., Nichelli F., Erbetta A., Usilla A., Vago C., and, Bulgheroni S., (2009) Cognition before and after chemotherapy alone in children with chiasmatic-hypothalamic tumors. J. Neurooncol. 92, 49-56.
41. Rubbi C. P., and, Milner J., (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22, 6068-6077. (Pubitemid 37463250)
42. Sano K., Miyaji-Yamaguchi M., Tsutsui K. M., and, Tsutsui K., (2008) Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS ONE 3, e4103.
43. Shaulian E., Zauberman A., Ginsberg D., and, Oren M., (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12, 5581-5592.
44. Shull E. R., Lee Y., Nakane H., Stracker T. H., Zhao J., Russell H. R., Petrini J. H., and, McKinnon P. J., (2009) Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23, 171-180.
45. Tsutsui K., Sano K., Kikuchi A., and, Tokunaga A., (2001) Involvement of DNA topoisomerase IIbeta in neuronal differentiation. J. Biol. Chem. 276, 5769-5778.
46. Whitney K. A., Lysaker P. H., Steiner A. R., Hook J. N., Estes D. D., and, Hanna N. H., (2008) Is "chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer. J. Support. Oncol. 6, 313-321.
47. Xiang H., Kinoshita Y., Knudson C. M., Korsmeyer S. J., Schwartzkroin P. A., and, Morrison R. S., (1998) Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18, 1363-1373. (Pubitemid 28082421)
48. Yang J. L., Weissman L., Bohr V. A., and, Mattson M. P., (2008) Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair (Amst) 7, 1110-1120.
49. Yankner B. A., Lu T., and, Loerch P., (2008) The aging brain. Annu. Rev. Pathol. 3, 41-66. (Pubitemid 351488276)
50. Yuan X., Zhou Y., Casanova E., Chai M., Kiss E., Grone H. J., Schutz G., and, Grummt I., (2005) Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell, 19, 77-87. (Pubitemid 40884659)
51. Zhang H., Wang J. C., and, Liu L. F., (1988) Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl Acad. Sci. USA 85, 1060-1064.